نتائج البحث - "Jan W. Eriksson"

1

Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes

المؤلفون: Priya Dipta, Maria J. Pereira, Francesca Forno, Miriam Shmuel, Martin Wabitsch, Morten Thaysen-Andersen, Boaz Tirosh, Xesús Abalo, Jan W. Eriksson, Assel Sarsenbayeva

المصدر: Comprehensive Psychoneuroendocrinology, Vol 7, Iss, Pp 100073-(2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b227af01f8da496562dc35169709ca73Test
http://www.sciencedirect.com/science/article/pii/S2666497621000473Test

2

Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes

المؤلفون: Prasad G. Kamble, Per Lundkvist, Russell Esterline, Maria J. Pereira, Anna Maria Langkilde, Jan W. Eriksson, Petros Katsogiannos, Eva Johnsson

المصدر: The Journal of Clinical Endocrinology & Metabolism. 104:193-201

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Adamantane, Type 2 diabetes, 030204 cardiovascular system & hematology, Biochemistry, 0302 clinical medicine, Endocrinology, Insulin, Glucose tolerance test, Cross-Over Studies, medicine.diagnostic_test, digestive, oral, and skin physiology, Dipeptides, Middle Aged, Glucose clamp technique, Treatment Outcome, Female, hormones, hormone substitutes, and hormone antagonists, Adult, endocrine system, medicine.medical_specialty, Adolescent, Sodium, chemistry.chemical_element, 030209 endocrinology & metabolism, Context (language use), Glucagon, Young Adult, 03 medical and health sciences, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Aged, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Biochemistry (medical), Glucose Tolerance Test, medicine.disease, Crossover study, Diabetes Mellitus, Type 2, chemistry, Glucose Clamp Technique, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9981bf62860579717393278dbebf5d93Test
https://doi.org/10.1210/jc.2018-00969Test

3

Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases : A large multinational observational study

المؤلفون: Suguru Okami, Nils Kossack, Anna Norhammar, Issei Komuro, Marcus Thuresson, Dae Jung Kim, Johan Bodegard, Ruiqi Zhang, Kyoung Hwa Ha, Jil Billy Mamza, Toshitaka Yajima, Jan W. Eriksson, Amitava Banerjee, Takashi Kadowaki, Kåre I. Birkeland

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, heart failure, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, Endocrinology and Diabetes, digestive system, DPP-IV inhibitor, Diabetic nephropathy, 03 medical and health sciences, chemistry.chemical_compound, DPP‐IV inhibitor, 0302 clinical medicine, Endocrinology, Japan, Germany, Republic of Korea, Internal Medicine, Humans, Medicine, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl peptidase-4, Sweden, Dipeptidyl-Peptidase IV Inhibitors, Norway, business.industry, diabetic nephropathy, Sodium, SGLT2 inhibitor, Original Articles, dapagliflozin, Middle Aged, medicine.disease, Glucose, Diabetes Mellitus, Type 2, England, chemistry, Cardiovascular Diseases, Sodium/Glucose Cotransporter 2, Heart failure, Endokrinologi och diabetes, Female, Original Article, Observational study, observational study, SGLT2 Inhibitor, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb5d82cb5854d17dc2343c5a5c0528bTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-439121Test

4

A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST) : Rationale, design and protocol

المؤلفون: Johan Sundström, Stefan Jansson, Björn Eliasson, Jan W. Eriksson, Ollie Östlund, Janeth Leksell, Martin Lundqvist, Robin Kristófi, Kristina E. Almby, Louise Bennet

مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Endocrinology and Diabetes, law.invention, chemistry.chemical_compound, Endocrinology, Randomized controlled trial, Diabetes complications, law, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Clinical endpoint, Humans, Hypoglycemic Agents, Registries, Dapagliflozin, Risk factor, Registry-based randomised controlled trials, Sodium-Glucose Transporter 2 Inhibitors, Randomized Controlled Trials as Topic, business.industry, Standard treatment, nutritional and metabolic diseases, medicine.disease, Metformin, chemistry, Diabetes Mellitus, Type 2, Endokrinologi och diabetes, business, SGLT2 inhibitors, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2421dfe386618132a58e7688b9c7cfTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456914Test

5

Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes

المؤلفون: F. Anders Karlsson, Kristina E. Almby, Maria J. Pereira, Magnus Sundbom, Prasad G. Kamble, Jan W. Eriksson, Petros Katsogiannos, Urban Wiklund

المصدر: The Journal of Clinical Endocrinology and Metabolism

مصطلحات موضوعية: 0301 basic medicine, Blood Glucose, Male, Time Factors, Endocrinology, Diabetes and Metabolism, Glucose uptake, Clinical Biochemistry, Adipose tissue, Type 2 diabetes, medicine.disease_cause, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Weight loss, Adipocyte, Medicine, T2D, adipose effects, Middle Aged, Obesity, Morbid, Adipose Tissue, Endokrinologi och diabetes, Female, medicine.symptom, AcademicSubjects/MED00250, Adult, medicine.medical_specialty, Gastric Bypass, 030209 endocrinology & metabolism, Context (language use), Endocrinology and Diabetes, 03 medical and health sciences, RYGB, Internal medicine, Humans, Online Only Articles, Clinical Research Articles, Aged, Sweden, business.industry, Gastric bypass surgery, Biochemistry (medical), nutritional and metabolic diseases, medicine.disease, Lipid Metabolism, neuroendocrine changes, Neurosecretory Systems, 030104 developmental biology, chemistry, Blood chemistry, Diabetes Mellitus, Type 2, Insulin Resistance, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7495d4559c96441e2d51312a0987434cTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-457938Test

6

A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes

المؤلفون: Jan Oscarsson, Peter J. Greasley, Jan W. Eriksson, Hiddo J.L. Heerspink, Viji Nair, Skander Mulder, Jonatan Hedberg, Wenjun Ju, Sunil B. Nagaraj, Ann Hammarstedt

المصدر: Diabetes, Obesity & Metabolism
Diabetes, Obesity and Metabolism

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, Endocrinology and Diabetes, Kidney, Nephropathy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Metabolomics, Glucosides, Diabetes mellitus, Internal Medicine, medicine, sodium-glucose co-transporter-2, Humans, Dapagliflozin, Benzhydryl Compounds, kidney function, Sodium-Glucose Transporter 2 Inhibitors, Symporters, business.industry, Sodium, Transporter, Original Articles, bioinformatics, dapagliflozin, medicine.disease, metabolomics, 3. Good health, Metabolic pathway, Glucose, chemistry, Diabetes Mellitus, Type 2, sodium‐glucose co‐transporter‐2, Endokrinologi och diabetes, Original Article, type 2 diabetes, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d417d44540cc7dd1c2beccd973a5516eTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-418709Test

7

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

المؤلفون: Maria J. Pereira, Per Lundkvist, Prasad G. Kamble, Julian G. Martins, C. David Sjöström, Jan W. Eriksson, Volker Schnecke, Eva Johnsson, Anna Walentinsson, Joey Lau

المصدر: Diabetes Therapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48097aa873ae8a0a1fc42e567463db27Test
https://doi.org/10.1007/s13300-018-0449-6Test

8

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes ( CVD‐REAL Nordic ) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

المؤلفون: Anna Norhammar, Bendix Carstensen, Johan Bodegard, David Nathanson, Marcus Thuresson, Thomas Nyström, Hanne L. Gulseth, Frederik Persson, Kåre I. Birkeland, Jan W. Eriksson, Marit E. Jørgensen, Peter Fenici

المصدر: Diabetes, Obesity and Metabolism. 20:344-351

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::45b254ad7bcf53ed6a5eff8483b51e18Test
https://doi.org/10.1111/dom.13077Test

9

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: S ustained reductions in body weight, glycaemia and blood pressure over 1 year

المؤلفون: Per Lundkvist, Maria J. Pereira, C. David Sjöström, Jan W. Eriksson, Petros Katsogiannos, Eva Johnsson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, obesity, Endocrinology, Diabetes and Metabolism, prediabetes, 030204 cardiovascular system & hematology, Body Mass Index, Impaired glucose tolerance, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Risk Factors, Prediabetes, Dapagliflozin, Adiposity, Middle Aged, Ghrelin, Cardiovascular Diseases, Endokrinologi och diabetes, Drug Therapy, Combination, Female, Original Article, medicine.drug, medicine.medical_specialty, exenatide, 030209 endocrinology & metabolism, Endocrinology and Diabetes, Placebo, Proof of Concept Study, Sodium-Glucose Transport Proteins, Drug Administration Schedule, Prediabetic State, 03 medical and health sciences, Double-Blind Method, Membrane Transport Modulators, Internal medicine, Diabetes mellitus, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Sweden, Venoms, business.industry, Original Articles, dapagliflozin, medicine.disease, Impaired fasting glucose, chemistry, Anti-Obesity Agents, Peptides, business, Body mass index, Exenatide, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c826239243e6eef8b385160c2f7fdfTest
https://doi.org/10.1111/dom.12954Test

10

Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study

المؤلفون: David Nathanson, Klas Rikner, Thomas Nyström, Marcus Thuresson, Anna Norhammar, Johan Bodegard, Jan W. Eriksson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, Type 2 diabetes, Endocrinology and Diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Internal medicine, Health care, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Dapagliflozin, Benzhydryl Compounds, education, Sodium-Glucose Transporter 2 Inhibitors, Aged, Sweden, education.field_of_study, business.industry, Health Care Costs, Original Articles, Middle Aged, medicine.disease, Hospitalization, chemistry, Diabetes Mellitus, Type 2, Endokrinologi och diabetes, Propensity score matching, Inclusion and exclusion criteria, Observational study, Female, Original Article, business, TIMI

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95ffc8694afbc5aabf5911187f98ba6Test
https://pubmed.ncbi.nlm.nih.gov/31379124Test

تنقيح النتائج